Touch Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Iotaiota.bioinMar 2026
iota Biosciences develops bioelectronic diagnostic and therapeutic devices using ultrasound technology to improve patient care.
BiotechDeep TechMedical DevicesBerkeley, US
Mike Woods(Chief Executive Officer)
Co-investorsHorizons VenturesPALETTE VENTURES
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.